Cargando…
Loss-of-function variants in CTNNA1 detected on multigene panel testing in individuals with gastric or breast cancer
PURPOSE: CTNNA1 is a potential diffuse gastric cancer risk gene, however CTNNA1 testing on multigene panel testing (MGPT) remains unstudied. METHODS: De-identified data from 151,425 individuals who underwent CTNNA1 testing at a commercial laboratory between October 2015 and July 2019 were reviewed....
Autores principales: | Clark, Dana Farengo, Michalski, Scott T., Tondon, Rashmi, Nehoray, Bita, Ebrahimzadeh, Jessica, Hughes, Sarah Kate, Soper, Emily R., Domchek, Susan M., Rustgi, Anil K., Pineda-Alvarez, Daniel, Anderson, Michael J., Katona, Bryson W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200596/ https://www.ncbi.nlm.nih.gov/pubmed/32051609 http://dx.doi.org/10.1038/s41436-020-0753-1 |
Ejemplares similares
-
Multigene Panel Testing Yields High Rates of Clinically Actionable Variants Among Patients With Colorectal Cancer
por: Coughlin, Sarah E., et al.
Publicado: (2022) -
Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management
por: Slavin, Thomas Paul, et al.
Publicado: (2015) -
Corrigendum: Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management
por: Slavin, Thomas Paul, et al.
Publicado: (2015) -
Non-targeted biopsies in hereditary diffuse gastric cancer: Necessary, but not enough
por: Buckley, Kole H., et al.
Publicado: (2023) -
Gastric Cancer Genomics: Advances and Future Directions
por: Katona, Bryson W., et al.
Publicado: (2017)